Table 3 Known groups’ validity: PSO-LIFE scores according to patient type, psoriasis status, localization, and disease severity
Groups | Mean PSO-LIFE score (SD) | P value |
|---|---|---|
Patient type | 0.03 | |
Psoriasis, n = 304 | 64.9 (22.5) | |
Control, n = 56 | 69.4 (17.3) | |
Psoriasis status | <0.01 | |
Active, n = 182 | 57.4 (20.4) | |
Inactive, n = 122 | 76.4 (20.6) | |
Localization | <0.01 | |
No lesions, n = 25 | 78.5 (21.6) | |
Trunk, lower extremities, n = 14 | 74.8 (23.9) | |
Head, upper extremities, n = 251 | 63.0 (21.9) | |
Psoriasis severity | <0.01 | |
Mild (PASI <10), n = 124 | 74.5 (22.0) | |
Moderate/severe ≥ 10, n = 166 | 57.8 (20.1) |